Company Description
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.
The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.
Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Country | United States |
| Founded | 2003 |
| IPO Date | Sep 15, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 354 |
| CEO | Leslie Trigg |
Contact Details
Address: 3052 Orchard Drive San Jose, California 95134 United States | |
| Phone | 669 231 8200 |
| Website | outsetmedical.com |
Stock Details
| Ticker Symbol | OM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $27.00 |
| CIK Code | 0001484612 |
| CUSIP Number | 690145107 |
| ISIN Number | US6901452069 |
| Employer ID | 20-0514392 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Leslie L. Trigg | President, Chief Executive Officer and Chairman |
| John L. Brottem J.D. | General Counsel and Secretary |
| Renee M. Gaeta | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer |
| Marc Nash | Executive Vice President of Research & Development, Operations and Service |
| James S. Mazzola | Vice President of Corporate Communications and Investor Relations |
| Laura Romike | Executive Vice President of Sales and Marketing |
| Amelia Merrill | Vice President of People Operations and Culture |
| Dr. Michael Aragon M.D. | Chief Medical Officer |
| Dinamarie Stefani | Senior Vice President of Regulatory Affairs and Quality Assurance |
| Brittni McGill | Chief Nursing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 15, 2025 | 144 | Filing |
| Aug 15, 2025 | 144 | Filing |
| Aug 15, 2025 | 144 | Filing |
| Aug 7, 2025 | 10-Q | Quarterly Report |
| Aug 6, 2025 | 8-K | Current Report |
| Jul 29, 2025 | SCHEDULE 13G | Filing |
| Jul 17, 2025 | SCHEDULE 13G | Filing |
| Jun 5, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 3, 2025 | 8-K | Current Report |
| May 29, 2025 | SD | Form - SD |